New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...
Many lung cancer patients now have access to a potentially life-saving medication. Osimertinib, sold under the brand name Tagrisso, is available to patients with Stage 1B-3A lung cancer who have a ...
A groundbreaking study published in JAMA Oncology in 2024 has upended traditional thinking surrounding breast cancer surgery. This expansive study, which tracked over 661,000 women over the course of ...
In a country where the glow of youthful hope is too often dimmed by the shadow of disease, Nigeria grapples with a crisis that has long been overlooked. Childhood cancer—once thought rare in ...
Two years after receiving an earth-shattering cancer diagnosis, and undergoing numerous surgeries and treatments, Shoemaker is sticking to his word. On April 21, the 26-year-old Shirley native — who ...
Many lung cancer patients now have access to a potentially life-saving medication. Osimertinib, sold under the brand name Tagrisso, is available to patients with Stage 1B-3A lung cancer who have a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results